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ABSTRACT
Aims: Description of a study protocol to analyze the effectiveness of the sequential
implementation of a Rapid Response System (RRS) on the incidence of the composite
endpoint of cardiac arrest, unplanned ICU admission, and mortality rates.
Study Design: The COMET trial is a before-after, non-randomized multi-center trial.
Place and Duration of Study: The COMET trial was held in the Netherlands in fourteen
Dutch hospitals from April 2009 until November 2011. Each hospital included two
surgical and two general medicine nursing wards.
Methodology: Prior to the introduction of the RRS, endpoints were collected for 5
months as part of a baseline assessment. The RRS was introduced in two steps. Initially,
two tools were introduced during 7 months for early detection of the deteriorating patient:
the Modified Early Warning Score (MEWS) and for structured communication, the
Situation-Background-Assessment-Recommendation (SBAR) tool. During the next 15
months the Rapid Response Team (RRT) was operational in addition to both the
detection and communication tool. Generalized Estimating Equations (GEE) analysis of
trends in outcomes will be performed. The cost description will primarily focus on the
program costs associated with training and education sessions and the time invested in
all consultations originating from patient care on the study wards.
Conclusion: The COMET study will provide evidence on the clinical outcomes and costs
of the implementation of Rapid Response System. This will include an analysis to
explore the possible effect of a Rapid Response Team as add-on to the MEWS and
SBAR tools for early recognition of the deteriorating patient on the nursing ward.
Keywords: Rapid response systems; modified early warning score; multicenter trial
effectiveness; deteriorating patient.
ABBREVIATIONS
COMET: Cost and Outcomes of Medical Emergency Teams; CPR: Cardio Pulmonary
Resuscitation; DNAR: Do Not Attempt Resuscitation; GEE: Generalized Estimating
Equations; ICC: Intra-class Correlation Coefficient; ICU: Intensive Care Unit; ITS: Interrupted
Time Series; LOS: Length of Stay; MET: Medical Emergency Team; MEWS: Modified Early
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Warning System; NICE: National Intensive Care Evaluation; RRS: Rapid Response System;
RRT: Rapid Response Team; SBAR: Situation-Background-Assessment-Recommendation;
TT: Track and Trigger
1. INTRODUCTION
Patient deterioration into critical illness on general nursing wards is generally preceded by
alterations in the physiological condition hours before an event occurs. This has been
demonstrated for cardiac arrests [1,2], unplanned ICU admissions [3,4] and (unexpected)
death [5]. The determinants of these events can potentially be recognized by measurement
of readily available vital parameters. Therefore, early recognition and intervention in this
patient group could potentially prevent adverse events from occurring. As a direct
consequence of these findings, RRS have been developed and were first described in 1995
by [6]. Up to this point, conclusive evidence regarding the effectiveness of the system is
absent [7].
Rapid Response Systems are built up from three distinct, but interacting components or
limbs [8]. The afferent limb is designed to detect the deteriorating patient by the use of Track
and Trigger (TT) systems. These are based on measurement of vital parameters and by
deviation of either a single or a combination of parameters (including scores) from a norm
which determines if a patient is at risk for deterioration. The efferent limb, the RRT, is
subsequently activated. An RRT is a combination of personnel originating from the ICU
which responds directly to the patient at the bedside. Finally, an administrative component
oversees data registration and analysis together with education of the care takers which are
required to operate the system components. These limbs are designed to protect the patient,
structure care processes to prevent patient deterioration and serious adverse events
including cardiac arrest. Taken together, they form a “chain of prevention” which should
ensure adequate response by all care-providers [9].
Despite the unproven nature of RRS, in 2009, a nationwide patient safety initiative has been
started in the Netherlands which describes the compulsory implementation of RRS in all
Dutch hospitals. This is further acknowledged by the Dutch government and Health
Inspectorate. The governmental directive of implementing RRS as soon as possible left no
room for the conduct of a randomized trial, but as hospitals needed time to prepare the
introduction and implementation of RRS type systems, the opportunity arose to conduct a
before-after multicenter trial into the clinical outcomes and costs of RRS type systems in the
Netherlands. This manuscript describes the corresponding study protocol.
2. METHODOLOGY
2.1 Objectives
The primary objective of this multicenter study is to evaluate the composite clinical outcome
of Rapid Response Systems, defined as the impact on cardiac arrest, unplanned ICU
admission, and mortality rate. Also, a secondary analysis will investigate to what extent the
impact on clinical outcome may be attributed to the afferent (early detection by a Track and
Trigger tool) or efferent (RRT) limb during the phased introduction. Furthermore, the
satisfaction of the primary applicants (nurses and doctors) will be assessed and a program
cost description (from a hospital perspective) will also be performed.
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2.2 Four Steps in a Before-After Design
The COMET study is a pragmatic before-after trial enabling a GEE (Generalized Estimating
Equation) analysis of trends in clinical outcome, based on monthly cardiac arrest, ICU
admission and mortality data. The study design is depicted in Fig. 1. The before period
consisted of 5 months in which baseline data were collected. Most hospitals were able to
provide these data prospectively. The implementation of RRS was divided into its two limbs.
Before MEWS/SBAR RRT After



















Fig. 1. Design of the COMET study
The COMET study was designed as a before-after study. Hospitals were able to start the study in a
three months time span based as logistics within each hospital was different. Following the baseline
period of 5 months, the MEWS/SBAR was implemented for 7 months and subsequently followed up by
15 months in which the RRT was available. During this phase and also the after period the entire
system was complete. During the entire study, all the endpoints were measured. Besides the before-
after comparison, time trend analysis on a monthly basis was also performed.
Initiation of the study was partly left at the discretion of participating hospitals because the
time constraints and inter-hospital variation in logistics wouldn’t allow a single starting point.
Within a restricted three month time frame, starting at the first day of each month between
April 2009 and July 2009, the baseline recordings were commenced. Within that same
timeframe, a minimum of four participants were trained in the ALERT™ [10] course at the
Radboud University Nijmegen Medical Center. In short, this course teaches how to
anticipate, recognize, and prevent critical illness at an early stage by providing classroom
sessions for theory followed up by multidisciplinary scenario practice. The first intervention
phase lasted 7 months during which the MEWS (Modified Early Warning Score) together
with the SBAR communication tool (Situation-Background-Assessment-Response
instrument) were implemented; Table 1 [11,12]. The MEWS and SBAR tools, and later on
the RRT, were introduced using a standardized toolkit in which the system was taught to
each care-giver. Applicants were also provided with plasticized handheld cards and
implementation was continued throughout the study period with posterson the wards, in
patient charts, feed-back session and face-to-face communication with personnel. During the
MEWS/SBAR phase, the RRT was not available and awareness of the subsequent
introduction of the team was absent since the MEWS/SBAR toolkit didn’t mention anything
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regarding the next phase. The RRT as add-on to the MEWS/SBAR tools continued for the
next 15 months, of which the final 5 months constituted the after measurement period. This
design enabled ample time for implementation of the system and would also provide insight
in the differential effectiveness of the MEWS/SBAR on the one hand and the RRT on the
other.
2.3 Further Details on the Interventions
Throughout the entire study period and therefore irrespective of the phase in the study, the
physicians and nurses adhered to the following procedure. Measurement of the vital
parameters, including frequency of measurements and MEWS, was not specifically
protocolized within the trial. It was defined ‘as clinically indicated’ in which the nurses and
physicians were instructed (using standardized toolkits for each study phase) to determine
the full MEWS (Table 1), whenever a patient’s vital parameter was outside normal range, for
example had a heart rate outside the 51-100 range, or a systolic blood pressure outside the
101-200 range, or a respiration rate outside the 9-14 range, or a temperature outside the
36.6-37.5 range, or whenever a patient was not alert or the nurse was worried about the
patient condition. Also the physicians could demand measurement of the MEWS at specific
intervals, when required. Whenever the score passed the threshold of 3 or more points, the
physician (on call) had to be directly notified and the communication had to be structured
using the SBAR tool (Table 2). This physician was a postgraduate resident in charge of all
patients at the ward or a (supervising) medical specialist and was at least trained and
certified according to the Fundamental Critical Care Support (FCCS) guidelines.
Fig. 2 shows the algorithm used for activation of the RRT during the RRT phase of the study.
It entailed that the physician had a maximum of 30 minutes to evaluate and set-up a
treatment plan for the patient after the nurse detected a patient with a MEWS of 3 or more.
After initiation of treatment (which may also contained direct notification of the RRT), a
maximum of 1 hour was available to evaluate the treatment effect. If the patient continued to
deteriorate or did not respond to treatment, the physician was instructed to activate the RRT
Within the system, an override option was incorporated. The nurse was able to directly
activate the RRT if the physician did not keep to the protocol (e.g. exceeding the prescribed
time limits for review and management of the patient) or in case the patient’s health status
did not improve (according to the nurse) an hour after initial treatment initiation.
In the MEWS/SBAR phase, the staff provided routine patient care. In response to the
detection of a patient with a MEWS of 3 or more, the physician would manage the patient “as
this would normally be performed” which could include assessment and consultation with
other specialties. No protocol or guidelines for initiation of treatment or consultation of
theICU was available. Therefore this phase enabled the analysis of the ability early detection
of the deteriorating patient employing the described tools specific tools without the specific
protocol for managing the patient after identification (i.e. time lines for treatment options
including the RRT).
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Table 1. The modified early warning score (MEWS)
MEWS score 3 2 1 0 1 2 3
Heart rate <40 40-50 51-100 101-110 111-130 >130
Systolic blood pressure <70 70-80 81-100 101-200 >200
Respiration rate <9 9-14 15-20 21-30 >30
Temperature <35,1 35,1-36,5 36,6-37,5 >37,5
AVPU score A (Alert) V (response to Voice) P (reacting to Pain) U (Unresponsive)
Worried about patient’s condition: 1 point
Urine production below 75 milliliter during last 4 hours : 1 point
Saturation below 90% despite adequate oxygen therapy: 3 points
Upon reaching 3 or more points → call resident in charge
The MEWS score was implemented as the tool for ward staff to identify the patient at risk of deterioration. The described method was
adapted from Subbe et al. [11]
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I’m calling about (name of patient, ward and room number)
The problem I’m calling about is (problem)
The vital parameters are (Heart rate, Blood pressure, Breathing rate, Saturation
with/without suppl. Oxygen, Temperature, AVPU scale, Urine production, other non-
specified parameters)
MMEWS score (score)
I’m concerned about (define problem)
B Background:
Admissions diagnosis and admission date
If relevant: Medical history and other clinical information
A Assessment:
I think the problem is (describe problem) or
I’m unsure what the problem is, but the patient (is deteriorating/unstable)
R Recommendation:
I think that you should (describe exactly what needs to happen at this moment)
1. Evaluate the patient now and/or
2. Evaluate the patient (set specific time interval) and/or
3. Determines medical policy
What should I do now?
How often do you want the vital parameters checked and at which thresholds do you
want to be called again?
Repeat-back:
We have agreed on the following (repeat the medical policy systematically and who
does what and when)
Write the determined policy up into the patients records
The SBAR method was introduced to facilitate complete and systematic handover over patient data
between the nurse and physician (on call) especially whenever a patient reached a MEWS of three or
more [12].
Deviation from the MEWS threshold was allowed in specific circumstances. For instance, in
case of a patient with chronic obstructive pulmonary disease with altered respiratory status
(e.g. maximum peripheral saturation of 85% with supplementary oxygen), a physician was
able to adjust the MEWS criteria accordingly because such patient would trigger at any time.
This could enclose alteration of thresholds for the MEWS cut off point of three points, but
also changes in thresholds for specific vital parameter(s). These adjustments had to be
documented in the nursing and medical charts for clear and an undisputable medical policy.
2.4 Setting and Participants
The COMET study is a multicenter study in which 14 Dutch hospitals participated. Two are
university hospitals (Academic Medical Center Amsterdam and Leiden University Medical
Center), nine are large teaching hospitals (BovenIJ Hospital, Catharina Hospital, Gelre
Hospital, Kennemer Gasthuis, Medical Center Alkmaar, Medical Spectrum Twente, Rijnland
Hospital, Sint Lucas Andreas Hospital and Zaans Medical Center) and three are smaller
regional hospitals (Diaconnessenhuis Leiden, Ikazia Hospital and Rivas Beatrix Hospital).
Each hospital included four study wards, 2 surgical and 2 medical based wards. The surgical
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type wards include general surgery wards, oncology type surgery, vascular, orthopedics etc.
Medical wards include internal medicine, nephrology, infectious diseases, pulmonology and
neurology.
All patients (age 18 or above), both electively and acutely admitted from home or from
another nursing ward onto the 4 study wards, were eligible for inclusion.
Fig. 2. Algorithm for activation of RRT
Algorithm for RRT activation. The algorithm displays the protocol of handling positive MEWS values
and all subsequent actions which either nurse or physician has to undertake together with set time
limits.
2.5 Outcome Measures and Definitions
The primary outcome is the composite endpoint of the first occurring cardiac arrest,
unplanned ICU admission or death per 1000 admitted patients on the four wards
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participating in the COMET study. The same composite endpoint per 1000 inpatient days at
these wards is considered a secondary outcome. The components of the composite
endpoint will also be assessed separately as secondary endpoints. Cardiac arrest was
defined as an event in which a respiratory and/or cardiac activity was absent and for which
the cardiac arrest team was called and started Cardio Pulmonary Resuscitation (CPR),
either using chemical resuscitation and/or manual chest compressions and/or respiratory
ventilation (irrespective of type). An unplanned ICU admission was defined as a situation in
which admission could not be delayed for the following 12 hours without risk. This data field
is a component of the Dutch national ICU registry (National Intensive Care Evaluation
(NICE)), which comprises a continuous and complete registry of all patients admitted to the
ICU’s of all participating hospitals [13]. Being a member of the NICE registry was mandatory
for hospitals to be able to participate in the COMET study.
Analysis of the secondary endpoint includes, according to the MERIT study, the incidence of
all cardiac arrests, unplanned ICU admissions, and deaths on the participating wards [14].
Thus, multiple endpoints per patient are possible with the exclusion of a subsequent
unplanned ICU admission after successful treatment following a cardiac arrest which is
deemed “appropriate care.” For these three endpoints, additional information such as
APACHE II and IV scores were collected upon admission to ICU and also whether chest
compressions and/or artificial ventilation was carried out with patients experiencing a cardiac
arrest.
Other secondary outcomes include: (1) Unexpected death defined as death without the
presence of any form of a Do Not Attempt Resuscitation (DNAR) order, which primarily
includes any form of restriction of active treatment, (2) Hospital Length of Stay (LOS), (3)
ICU length of stay, (4) numbers of RRT calls per 1000 admitted patients and per 1000
inpatient days and (5) program costs from a hospital perspective based on team composition
and duration of activation during a cardiac arrest, ICU or RRT consultation. Other process
parameters will be measured which include a multiple choice written test to be made after
each education session in which (based on a case description) the correct action needs to
be chosen. Also, at three set time points during the COMET study, a questionnaire will be
administered among the nurses and physicians on the included wards regarding their
satisfaction with the protocol and its components and perceived benefit of the system. These
items were anonymously administered, processed and analyzed. Finally, the number of
patients with a primary endpoint without RRT call in the preceding 24 hours per 1000
admitted patients will also be calculated to analyze for possible delay and protocol
deviations.
2.6 Sample Size
This study is powered to determine the effectiveness of an RRS. First of all, the incidence of
cardiac arrest presumably ranges between 4 and 11 per 1000 admissions [14,15]. The
incidence of unplanned ICU admissions in patients on general hospital wards has been
estimated at 5/1000 admissions [17].
At the Academic Medical Center (AMC), from 2005 to 2009 (4 years), 100,000 patients were
admitted to the hospital. In that same time period, 686 patients (6.9/1000 admissions) were
admitted (unplanned) from the general ward to the ICU (re-admissions excluded). Based on
the literature and historical AMC data, we anticipate that in the control period 10/1000
admitted patients will reach the primary endpoint (resuscitation, unplanned ICU admission
and death) and that this number decreases to 6/1000 during the intervention period, a
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reduction by 40%. Fourteen hospitals will participate in this study, each with four wards. In
the pre-post study design, these four wards will be clustered by two (surgery versus general
wards). The study will thus contain 28 (2*14) clusters. With 28 clusters and a total of 5 time
periods in the control (phase 1) and 5 time periods during the RRT intervention (phase 3), 99
patients are needed per cluster per time period to reject the null hypothesis that the
difference between the intervention period and the control period is smaller than 0.004 [18]
with a power of 80% and a one-sided significance level of 0.05. The total number of eligible
patients to be included amounts to 27,720 (2*28*5*99). The intra-class correlation coefficient
(ICC) used for this calculation is 0.00254. This ICC was derived from the ICC observed
(0.00127) in a non-randomised study of three hospitals [19], but it was doubled to account
for higher ICCs than one anticipates [14].
The training in MEWS in phase 2 may also exert influence on the primary outcome measure,
but probably less than the combined intervention including the RRT [8]. For lack of power to
detect a difference between MEWS only and MEWS+RRT phase, the data gathered during
the MEWS phase will only be used for exploration and hypothesis generation. To this end,
data will be gathered during 7 time periods with a total of 19,404 (7*28*99) admitted patients.
2.7 Data Acquisition and Analysis
Data for the COMET study were taken from multiple existing hospital and nationwide (NICE
registry) databases. Hospitals were primarily conducting their own data acquisition,
registered the data on Case Record Forms (CRF) and entered the source data into an
internet database. This enabled data monitoring by the study coordinators while not on site.
Most data were prospectively collected, except for baseline data in some hospitals.
However, this partial retrospective data gathering did not result in a loss of information,
because the procedures and extent of data extraction from the existing databases were
identical to procedures during prospective data collection.
The main analysis will focus on the before-after comparison of the primary composite
endpoint in which all separate events are presumed to be potentially avoidable. This
includes the earlier mentioned exception of an unplanned ICU admission after cardiac arrest.
The total number of 28 clusters over 10 time periods justifies the use of generalized
estimating equations (GEE) for statistical analysis of the data. Generalized estimating
equations can flexibly handle normal or non-normal endpoints; tend to be more robust to
misspecification of the variance structure than (generalized) linear mixed modeling. It is a
natural choice for individual-level binary outcomes and may automatically account for
variable cluster sizes if they occur [20].
The analysis will account for the segmented pre- and post-intervention phases into the 5
distinct time periods per phase. The generalized model will include terms for the baseline
level of occurring events, the pre-intervention trend over time, the impact of the intervention,
the post-intervention trend over time, autocorrelation over time within clusters, and error [21].
Additional analyses include a descriptive of the first endpoint encountered by patients by
study phase and by time period, as well as GEE-based exploratory analyses contrasting the
MEWS/SBAR phase against the RRT phase. Moreover, possible learning curves in the
recognition of deteriorating patients will be studied through test and questionnaire, which are
part of the toolkits for each phase of the trial. Satisfaction with the RRS and its components
is assessed by regular distribution of questionnaires among the users of the system. The
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results from these questionnaires will indicate the perceived boundaries in using the system
(e.g. ease of use MEWS, activation of RRT).
Dose response analysis according to Chen et al. [22] will be performed to examine possible
impact of early review of critically ill ward patients in relation to RRT activation. Taken
together, these analyses will portray a clear image of the RRS system within each hospital
and by meta-analysis in all COMET hospitals.
2.8 Cost Description
A partial economic evaluation will be performed, restricted to the description of the direct
medical costs of the index admission. This provider (hospital) perspective has been chosen
because of the high number of patients to be included and the low incidence of the primary
outcome measure in the study. For the same reasons no patient outcome analysis
concerning quality of life is planned. The time horizon of the study is the index admission.
The cost components include (i) the training of nurses and physicians in recognizing early
warning signs, (ii) installation of RRTs, (iii) (intensive) monitoring and treatment of (vitally
threatened) patients, (iv) (ICU) inpatient days and (v) resuscitations. Volume data will be
retrieved from hospital information systems and the NICE database. Unit costs of hospital
activities will be derived from national guidelines for costing in health care research [23,24]
or, if these guidelines seem unsuitable for that purpose, from available local unit costs in
participating reference hospitals. Activity based costing of RRT will be applied for all
hospitals and based on the detailed monitoring of RRT activities. The costs of MEWS and
subsequent RRT training will be based on pre-calculation of the related program costs,
including the time investment of trainees. Costs will be estimated for the base year 2011
after price indexing.
Based on the cost description and the difference in event rate between the pre- and post-
intervention periods, we will tentatively perform an incremental cost-effectiveness analysis
showing the extra provider costs per resuscitation, unplanned ICU-admission and death
prevented. Sensitivity analyses will be performed for different levels of economies of scale
and capacity utilization which influence the availability costs of rapid response teams. The
unit costs of an RRT per admission or per recognized vital threat depend on the total number
of admissions for which the team is available. The present study will contribute to determine
optimal levels of RRT capacity, relative to its unit costs.
2.9 Ethics and Informed Consent
The medical ethics committee (METC) of the Academic Medical Center in Amsterdam
waived the need for formal evaluation of the study due to the obligatory nature of the
intervention and the observational nature of the study. Consequently, the need for informed
consent was not applicable. The trial was registered at the Dutch Trial Register under
number TC2706. All authors hereby declare that all experiments have been examined
performed in accordance with the ethical standards laid down in the 1964 Declaration of
Helsinki.
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3. DISCUSSION
The COMET trial is a multicenter, non-randomized before-after trial with the ability to perform
GEE analysis to evaluate the effectiveness and costs associated with implementation of an
RRS within the fourteen participating Dutch hospitals. The COMET trial consists of the
phased implementation of RRS. It starts with the use of MEWS/SBAR tools to detect and
communicate about a clinically deteriorating patient. Seven months later the second
component of RRS, the physician based RRT which can be warned by ward personnel, is
introduced. This phased implementation enables not just the evaluation of the RRS as the
combination of MEWS/SBAR and RRT (comparing the after and before measurements); it
also allows for exploration of the impact of the RRT as add-on to the use of only the
MEWS/SBAR tools (comparing the measurement during the MEWS/SBAR period with the
before measurement and with the after measurement).
To our knowledge, this has never been fully attempted on this scale although Priestley et al.
have shown reduction in hospital LOS and in-hospital mortality in the training group which
had just been trained in the use of the afferent limb [17]. The COMET study is held within the
Netherlands where mandatory implementation of an RRS is required by the Health
Inspectorate. This enabled a unique opportunity to initiate a multicenter study in which a
representative population of Dutch hospitals is present and external validity of the data is
perceived to be high. Recently, an editorial by Bellomo et al. has shown that single center
trials often show positive results which are not held up in multicenter trials [25]. Much of the
scientific knowledge regarding RRS is derived from many mono center or even mono ward
trials with less rigorous study designs. Therefore, reticence should be present regarding
these data. The COMET study, despite absence of randomization but including an
innovative time phased introduction over a substantial timeframe of a RRS, should provide
new insight in the effectiveness of the system and, to a lesser extent, each of its
components, the MEWS/SBAR and RRT.
The internal validity of research into ‘complex interventions’, is often at stake and optimal
trial design is challenging [26,27]. Randomized controlled trials, in respect to RRS, are
merely impossible to conduct. Several reasons for this are present. Prior to the
governmental directive on RRS implementation, the COMET study was set up as cluster
randomized controlled trial (RCT) following the methodology of a stepped wedge trial. [20]
Within this design, not hospitals but the two pairs of wards were randomized for the initiation
of the RRS so that there was always a parallel control group from the same hospital present.
In the end, all four wards of each hospital would have taken up the intervention. This design
or an RCT in which hospitals would be randomized as either placebo or intervention hospital
(MERIT study), were too hard to accomplish due to the mandatory nature of RRS in the
Netherlands in which every hospital at a certain time point should have an RRS, but also due
to problems encountered in the MERIT study including potential contamination in a parallel
design [27].
Furthermore, complex interventions are difficult to study because they are built up from
components that may act both independently and inter-dependently. Also, they are adaptive
to changes in their local environments and behave in a non-linear fashion [26]. Standards of
nursing care, education and commitment of all associated health care workers within an
RRS are required to be able to correctly assess the program’s effectiveness.
The COMET trial is a pragmatic trial in which RRS has to proof itself in the flexible and real-
time workspace of general practice. It lacks the sometimes “artificial nature” of more
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stringent, protocolized studies, thereby gaining in clinical relevance against, perhaps, a
slightly increased risk of a lower internal validity. One manifestation of the pragmatic
approach is that the MEWS is determined ‘on indication’ rather than set at specific intervals
and on all patients. This mirrors the clinical practice to a large extent in which no specific
guidelines are present regarding measurement of vital signs. On the surface, frequent
measurement of complete sets of vital signs should hypothetically increases the chance of
identifying a deteriorating patient, but the clinical relevance of our pragmatic approach is
supported by two papers showing that fixed measurements of vital signs show low positive
predictive power on adverse events [28,29]. Furthermore, the COMET study employs a
physician based RRT rather than a nurse led team or a step up procedure in which a
physician is called when indicated by the RRT nurse. No evidence exists what composition
is more effective; however, it is generally perceived that a physician led team is able to
directly initiate therapy which nurses aren’t allowed to. The RRT within the COMET study is
staffed 24/7 and the minimal competency level of the RRT physician is Fundamental Critical
Care Support (FCCS) trained. This ensures, together with the ICU nurse, adequate
knowledge and skills levels regarding assessment and treatment options at the bedside of
the patient at risk. A final possible limitation of the study lies in the starting point of the study.
Because the pressure on hospitals in 2009 to initiate the implementation of the RRS, led to
logistical issues for the hospitals which participated in the COMET study. For some
hospitals, the organization of also entering the study was minimal. For some it was a bit
more challenging. To account for this, hospitals were entitled to initiate the study within a
three month time frame, allowing them to start the RRS while being equally well prepared.
This minimized the risk of different learning curves early in the study, which would have
influenced hospital performance during the MEWS/SBAR phase.
The COMET study is innovative, because it will investigate for the first time, the degree of
satisfaction of the care-givers in all participating hospitals and at ward level. This will support
the interpretation of possible differences in outcome parameters among hospitals and/or
wards, that directly relate to the care givers’ opinions regarding (ease) of use of RRS
components, perceived effectiveness, but also issues regarding past experiences of RRT
members. Finally, because of the sequential introduction of the afferent limb prior the RRT,
the additive effect of the RRT on sole, hypothetically earlier recognition of the deteriorating
patient, can be studied. Recent evidence suggests that this may indeed be beneficial [30].
An RRS can potentially take up much effort during its implementation in hospital
organizations, as suggested by a recent postal survey in the Netherlands [31].
Implementation depends on the willingness among many health care workers to contribute,
despite interference with “normal day-to-day” routines. Hence, implementation outcome
measures were incorporated in our study design to facilitate the interpretation of the findings.
In contrast with the MERIT trial and the trial by Priestley [14,17] accounting for these
implementation outcome measures will increase the study duration up to 2.5 years.
4. CONCLUSION
In conclusion, the COMET trial will provide new and important insights into the functioning of
an RRS and has incorporated as much insights regarding the analysis of complex
interventions.
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